Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Nasdaq, S&P 500 rebound as Amazon surges, market shrugs off jobs data
05:15pm, Friday, 01'st Nov 2024
US stocks staged a comeback on Friday as investors digested a big miss in the monthly jobs report and welcomed Amazon (AMZN) and Intel (INTC) earnings. The tech-heavy Nasdaq Composite (^IXIC) gained 0
Lilium N.V. Receives Notice of Delisting from Nasdaq
04:32pm, Friday, 01'st Nov 2024
MUNICH, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (Nasdaq: LILM) (the “Company” or “Lilium”), a leading electric aircraft manufacturer and pioneer in Regional Air Mobility (RAM), on Tuesda
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 01'st Nov 2024
DALLAS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-b
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:26pm, Friday, 01'st Nov 2024
BOSTON , Nov. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on October 31, 2024
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 01'st Nov 2024
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on November 1, 2024, the Compensation Committee of the company's Board of Directors granted
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 01'st Nov 2024
BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 01'st Nov 2024
REDWOOD CITY, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 01'st Nov 2024
CAMBRIDGE, Mass. , Nov. 1, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, grant
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 01'st Nov 2024
NEWTON, Mass. , Nov. 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
04:00pm, Friday, 01'st Nov 2024
Ji'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Co
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
12:26pm, Friday, 01'st Nov 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday.
Nasdaq, S&P 500 rebound amid Amazon cheer, jobs report
12:08pm, Friday, 01'st Nov 2024
US stocks jumped and were set for a comeback on Friday as investors digested a big miss in the monthly jobs report and welcomed Amazon (AMZN) and Intel (INTC) earnings. The tech-heavy Nasdaq Composite
PS International Group Ltd. Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
11:00am, Friday, 01'st Nov 2024
Hong Kong, Nov. 01, 2024 (GLOBE NEWSWIRE) -- PS International Group Ltd. (NASDAQ: PSIG) (“PSIG” or the “Company”), a long-established global logistics service provider headquartered in Hong Ko
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
10:34am, Friday, 01'st Nov 2024
HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Marke
S&P 500 and Nasdaq 100: Tech Stocks Lift Futures Ahead of Key Jobs Report
08:27am, Friday, 01'st Nov 2024
Nasdaq 100 futures rise on Amazon, Intel gains; traders await key U.S. jobs data for insights into tech stock momentum.
